Private Advisor Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-54,808
| Closed | -$225K | – | 2292 |
|
|
2022
Q1 | $225K | Sell |
54,808
-8,969
| -14% | -$32.5K | ﹤0.01% | 1835 |
|
|
2021
Q4 | $228K | Sell |
63,777
-56,617
| -47% | -$198K | ﹤0.01% | 1863 |
|
|
2021
Q3 | $437K | Buy |
120,394
+42,199
| +54% | +$171K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $341K | Sell |
78,195
-30,008
| -28% | -$122K | ﹤0.01% | 1578 |
|
|
2021
Q1 | $445K | Buy |
108,203
+19,265
| +22% | +$83.5K | ﹤0.01% | 1362 |
|
|
2020
Q4 | $355K | Sell |
88,938
-13,800
| -13% | -$44.6K | ﹤0.01% | 1389 |
|
|
2020
Q3 | $279K | Buy |
102,738
+3,000
| +3% | +$8.3K | ﹤0.01% | 1283 |
|
|
2020
Q2 | $274K | Sell |
99,738
-24,650
| -20% | -$68.8K | ﹤0.01% | 1242 |
|
|
2020
Q1 | $294K | Sell |
124,388
-1,600
| -1% | -$5.44K | 0.01% | 1082 |
|
|
2019
Q4 | $592K | Buy |
125,988
+737
| +0.6% | +$3.02K | 0.01% | 974 |
|
|
2019
Q3 | $421K | Hold |
125,251
| – | – | 0.01% | 1144 |
|
|
2019
Q2 | $412K | Buy |
125,251
+21,871
| +21% | +$63.3K | 0.01% | 1131 |
|
|
2019
Q1 | $313K | Buy |
103,380
+36,964
| +56% | +$120K | 0.01% | 1177 |
|
|
2018
Q4 | $181K | Buy |
+66,416
| New | +$219K | ﹤0.01% | 1226 |
|
Other funds holding ATRS
Private Advisor Group's ATRS Position: Q2 2022 in Review
Private Advisor Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 54,808 shares — an estimated $225K sold.
Private Advisor Group first reported a position in ATRS in Q4 2018 and held it in 14 quarters. The position peaked at $592K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Private Advisor Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Private Advisor Group sold 54,808 Antares Pharma, Inc. shares in Q2 2022, an estimated $225K.
- Private Advisor Group first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 14 quarters.
- Private Advisor Group's Antares Pharma, Inc. position peaked at $592K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Private Advisor Group's 13F filing for Q2 2022, filed 13 Jul 2022.